Cigna executives kicked off Thursday’s earnings call by responding to pharmacy benefit manager critics with a number of reforms.

Cigna has deleveraged substantially after acquiring Express Scripts in late 2018 when Cigna's debt rose to over $42 billion, or debt/capital of 51%. Management has made good progress on its ...

Management projects 2025 adjusted EPS of at least $29.50, supported by biosimilar growth and strategic investments. Full-year consolidated adjusted revenue is expected to exceed $252 billion.

CVS's app is designed as a one-stop shop for customers to do everything from manage prescriptions to opening locked display ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors ...

Fresh off underperforming Wall Street’s expectations in the fourth quarter, Cigna said it would work to lower costs for its ...

Healthcare stocks have been under the weather for the past few years, underperforming the broader market’s rally despite ...

Cigna's Evernorth Health Services said on Wednesday its actions will enhance transparency about the company's negotiations.

In a recent antitrust arbitration ruling, Prime Therapeutics, a pharmacy benefit manager (PBM) owned by 19 Blue Cross and ...

As the rising cost of insulin continues to make it difficult for so many diabetic patients to receive life-saving care, ...

Independent drugstores are closing at an alarming rate, squeezed by the huge companies that reimburse pharmacies for costly ...

Oklahoma's attorney general has accused CVS's Caremark pharmacy benefit manager unit of under-reimbursing pharmacies for ...